Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-06-001069
Filing Date
2006-05-09
Accepted
2006-05-08 17:37:00
Documents
5
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bp71842.htm 10-Q 278051
2 EXHIBIT 31.1 bp71842ex311.htm EX-31.1 14069
3 EXHIBIT 31.2 bp71842ex312.htm EX-31.2 14043
4 EXHIBIT 32.1 bp71842ex321.htm EX-32.1 3028
5 EXHIBIT 32.2 bp71842ex322.htm EX-32.2 3093
  Complete submission text file 0001206774-06-001069.txt   313696
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 06817944
SIC: 2836 Biological Products, (No Diagnostic Substances)